The trend of globalization in the pharmaceutical industry has been gaining momentum recent years.
As a member of Kanematsu group, we make the best use of its more than 40 branch offices overseas to import and export wide range of, active pharmaceutical ingredients (APIs), finished dosage products and intermediates from R&D to various stages of clinical trial and assist our customers to obtain and maintain approval of their products to meet the needs of pharmaceutical regulatory affairs and quality assurance in Japan.
We have three GMP-compliant pharmaceutical warehouses in Tokyo, where we are prepared to have an audit from Japan’s health regulatory authority and pharmaceutical companies, thus, meeting customers’ needs.

We hold various licenses required for pharmaceutical trading business in Japan, including marketing authorization (packaging, labeling and storing), pharmaceutical wholesale license, and psychotropic drug import license.

■Major products
• ・Import/export of:
  APIs, finished dosage products (lifestyle disease drugs, antibiotics, anticancer drugs, central nervous system agents, antitubercular drugs, etc.), pharmaceutical Intermediates/additives, fine chemicals
• ・Support for obtaining approval/license:
  Serving as an in-country caretaker (ICC) of drug master files (DMFs) in Japan, application for Foreign Manufacturer Accreditation, handling Good Manufacturing Practices (GMP) compliance inspection for foreign manufacturers (preparing documents/accompanying onsite inspections)

Please contact us at TEL: +81-3-5643-3012 or FAX: +81-3-5643-3022